The neurobiology of postpartum depression

CNS Spectrums

Volumn 10, Issue 10, 2005, Pages

  Zonana, Jessica ^a   Gorman, Jack M ^b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ARGIPRESSIN; BIOGENIC AMINE; CHOLESTEROL; ESTROGEN; FATTY ACID; NEUROSTEROID; OXYTOCIN; PROGESTERONE; PROLACTIN; TESTOSTERONE;

DEPRESSION; FEMALE; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MENSTRUAL CYCLE; MENTAL DISEASE; MOOD DISORDER; NEUROBIOLOGY; NEUROIMAGING; NEUROPSYCHIATRY; PREGNANCY; PRIORITY JOURNAL; PSYCHOSIS; PUERPERAL DEPRESSION; PUERPERIUM; REVIEW; RISK FACTOR;

EID: 27444434237     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1092852900010312     Document Type: Review

References (81)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. Sadock BJ, Sadock VA. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 7th ed. CDRom version. New York, NY: Lippincott Williams & Williams; 2000:1276-1283.
3. Bloch M, Daly RC, Rubinow DR. Endocrine factors in the etiology of postpartum depression. Compr Psychiatry. 2003;44:234-246.
4. O'Hara MW, Schlechte JA, Lewis DA, Varner MW. Controlled prospective study of postpartum mood disorders: Psychological, environmental, and hormonal variables. J Abnorm Psychol. 1991;100:63-73.
5. Hannah P, Adams D, Lee A, Glover V, Sandler M. Links between early post-partum mood and post-natal depression. Br J Psychiatry. 1992;160:777-780.
6. Henshaw C, Foreman D, Cox J. Postnatal blues: a risk factor for postnatal depression. J Psychosom Obstet Gynaecol. 2004;25:267-272.
7. Miller LJ. Postpartum depression. JAMA. 2002;287:762-765.
8. Flores DL, Hendrick V. Etiology and treatment of postpartum depression. Curr Psychiatry Rep. 2002;4:461-466.
9. Mastorakos G, Ilias I. Maternal hypothalamic-pituitary-adrenal axis in pregnancy and the postpartum period: Postpartum-related disorders. Ann N Y Acad Sci. 2000;900:95-106.
10. Magiaku M, Mastorakos G, Rabin D, Dubbert B, Gold PW, Chrousos GP. Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: Implications for the increase in psychiatric manifestations at this time. J Clin Endocrinol Metab. 1996;81:1912-1917.
11. O'Hara MW, Schlechte JA, Lewis DA, Wright EJ. Prospective study of postpartum blues. Biologic and psychosocial factors. Arch Gen Psychiatry. 1991;48:801-806.
12. Feksi A, Harris B, Walker RF, Riad-Fahmy D, Newcombe RG. 'Maternity blues' and hormone levels in saliva. J Affect Disord. 1984;6:351-355.
13. Nott PN, Franklin M, Armitage C, Gelder MG. Hormonal changes and mood in the puerperium. Br J Psychiatry. 1976;128:379-383.
14. Harris B, Johns S, Fung H, et al. The hormonal environment of post-natal depression. Br J Psychiatry. 1989;154:660-667.
15. Kuevi V, Causon R, Dixson AF, et al. Plasma amine and hormone changes in 'postpartum blues'. Clin Endocrinol (Oxf). 1983;19:39-46.
16. Nappi RE, Petraglia F, Luisi S, Polatti F, Farina C, Genazzani AR. Serum allopregnanolone in women with postpartum "blues". Obstet Gynecol. 2001;97:77-80.
17. Buckwalter JG, Stanczyk FZ, McCleary CA, et al. Pregnancy the postpartum, and steroid hormones: effects on cognition and mood. Psychoneuroendocrinology. 1999;24:69-84.
18. Hohlagschwandtner M, Husslein P, Klier C, Ulm B. Correlation between serum testosterone levels and peripartal mood states. Acta Obstet Gynecol Scand. 2001;80:326-330.
19. Abou-Saleh MT, Ghubash R, Karim L, Krymski M, Bhai I. Hormonal aspects of postpartum depression. Psychoneuroendocrinology. 1998;23:465-475.
20. Gard PR, Handley SL, Parsons AD, Waldron G. A multivariate investigation of postpartum mood disturbance. Br J Psychiatry. 1986;148:567-575.
21. Harris B, Lovett L, Newcombe RG, Read G, Walker RF, Riad-Fahmy D. Maternity blues and major endocrine changes: Cardiff puerperal mood and hormone study II. BMJ. 1994;308:949-953.
22. Heidrich A, Schleyer M, Spingler H, et al. Postpartum blues: relationship between not-protein bound steroid hormones in plasma and postpartum mood changes. J Affect Disord. 1994;30:93-98.
23. Harris B, Lovett L, Smith J, Read G, Walker R, Newcombe RG. Cardiff puerperal mood and hormone study. III. Postnatal depression at 5 to 6 week postpartum, and its hormonal correlates across the peripartum period. Br J Psychiatry. 1996;168:739-744.
24. Rupprecht R, Holsboer F. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci. 1999;22:410-416.
25. Stell BM, Brickley SG, Tang CY, Farrant M, Mody I. Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptor. Proc Natl Acad Sci U S A. 2003;100:14439-14444.
26. Cabrera RJ, Bregonzio C, Laconi M, Mampel A. Allopregnanolone increase in striatal N-methyl-D-aspartic acid evoked [3H]dopamine release is estrogen and progesterone dependent. Cell Mol Neurobiol. 2002;22:445-454.
27. Romeo E, Strohle A, Spalletta G, et al. Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry. 1998;155:910-913.
28. Strohle A, Romeo E, Hermann B, et al. Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol Psychiatry. 1999;45:274-277.
29. Freeman EW, Frye CA, Rickels K, Martin PAG, Smith SS. Allopregnanolone levels and symptom improvement in severe premenstrual syndrome. J Clin Psychopharmacol. 2002;22:516-520.
30. Pearson Murphy BEP, Steinberg SI, Fen-Yun H, Allison CM. Neuroactive ring A-reduced metabolites of progesterone in human plasma during pregnancy: elevated levels of 5a-dihydroprogesterone in depressed patients during the latter half of pregnancy. J Endocrinol Metab. 2001;86:5981-5987.
31. Okano T, Nomura J. Endocrine study of the maternity blues. Prog Neuropsychopharmacol Biol Psychiatry. 1992;16:921-932.
32. George AJ, Copeland JRM, Wilson KCM. Prolactin secretion and the postpartum blues syndrome. Proceedings of the British Pharmacological Society Meeting. 9th-11th April. Abstract 102P.
33. Insel TR, Hulihan TJ. A gender-specific mechanism for pair bonding: oxytocin and partner preference formation in monogamous voles. Behav Neurosci. 1995;109:782-789.
34. Ferguson JN, Young LJ, Hearn EF, Matzuk MM, Insel TR, Winslow JT. Social amnesia in mice lacking the oxytocin gene. Nat Genet. 2000;25:284-288.
35. Rosenblum LA, Smith EL, Altemus M, et al. Differing concentrations of corticotropin-releasing factor and oxytocin in the cerebrospinal fluid of bonnet and pigtail macaques. Psychoneuroendocrinology. 2002;27:651-660.
36. Neumann ID, Torner L, Wigger A. Brain oxytocin: differential inhibition of neuroendocrine stress responses and anxiety-related behaviour in virgin, pregnant and lactating rat. Neuroscience. 2000;95:567-575.
37. Sanders G, Freilicher J, Lightman SL. Psychological stress of exposure to uncontrollable noise increases plasma oxytocin in high emotionality women. Psychoneuroendocri nology. 1990;15:47-58.
38. Turner RA, Altemus M, Enos T, Cooper B, McGuinness T. Preliminary research on plasma oxytocin in normal cycling women: investigating emotion and interpersonal distress. Psychiatry. 1999;62:97-113.
39. Nomura M, Saito J, Ueta Y, Muglia LJ, Pfaff DW, Ogawa S. Enhanced up-regulation of corticotropin-releasing hormone gene expression in response to restraint stress in the hypothalamic paraventricular nucleus of oxytocin gene-deficient male mice. J Neuroendocrinol. 2003;15:1054-1061.
40. Keck ME, Welt T, Muller MB, et al. Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology. 2003;28:235-243.
41. Wigger A, Sanchez MM, Mathys KC, et al. Alterations in central neuropeptide expression, release and receptor binding in rats bred for high anxiety: critical role of vasopressin. Neuropsychopharmacology. 2004:1-14.
42. Purba JS, Hoogendijk WJ, Hofman MA, Swaab DF. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry. 1996;53:137-143.
43. Pitts AF, Samuelson SD, Meller WH, Bissette G, Nemeroff CB, Kathol RG. Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls. Biol Psychiatry. 1995;38:330-335.
44. van Londen L, Goekopp JC, van Kempen GMJ, et al. Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology. 1997;17:284-292.
45. van Londen L, Kerkhof GA, ven den Berg F, et al. Plasma arginine vasopressin and motor activity in major depression. Biol Psychiatry. 1998;43:196-204.
46. Bethea CL, Lu NZ, Gundlah C, Streicher JM. Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol. 2002;23:41-100.
47. Shively CA, Bethea CL. Cognition, mood disorders, and sex hormones. ILAR J. 2004;45:189-199.
48. Newport DJ, Owens MJ, Knight DL, et al. Alterations in platelet serotonin transporter binding in women with postpartum onset major depression. J Psychiatr Res. 2004;38:467-473.
49. Stein G, Milton F, Bebbington P, Wood K, Coppen A. Relationship between mood disturbances and free and total plasma tryptophan in postpartum women. Br Med J. 1976;2:457.
50. Maes M, Ombelet W, Verkerk R, Bosmans E, Scharpe S. Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and early post-partum anxiety and depression. Psychol Med. 2001;31:847-858.
51. Nonacs RM, Soares CN, Viguera AC, Pearson K, Poitras JR, Cohan LS. Bupropion SR for the treatment of postpartum depression: a pilot study. Int J Neuropsychopharmacol. 2005;8:445-449.
52. Appleby L, Warner R, Whitton A, Faragher B. A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ. 1997;29;314:932-936.
53. Misri S, Reebye P, Corral M, Milis L. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial. J Clin Psychiatry. 2004;65:1236-1241.
54. Wisner KL, Perel JM, Peindl KS, Hanusa BH, Piontek CM, Findling RL. Prevention of postpartum depression: a pilot randomized clinical trial. Am J Psychiatry. 2004;161:1290-1292.
55. Thompson TL. Attenuation of dopamine uptake in vivo following priming with estradiol benzoate. Brain Res. 1999;834:164-167.
56. Thompson TL, Moore CC, Smith B. Estrogen priming modulates autoreceptor-mediated potentiation of dopamine uptake. Eur J Pharmacol. 2000;401:357-363.
57. Thompson TL, Moss RL. Estrogen regulation of dopamine release in the nucleaus accumbens: genomic- and nongenomic-mediated effects. J Neurochem. 1994;62:1750-1756.
58. Levesque D, Di Paolo T. Modulation by estradiol and progesterone of the GTP effect on striatal D-2 dopamine receptors. Biochem Pharmacol. 1999;45:723-733.
59. Thompson TL, Certain ME. Estrogen mediated inhibition of dopamine transport in the striatum: regulation by G alpha i/o. Eur J Pharmacol. 2005;511:121-126.
60. van Hartesveldt C, Joyce JN. Effects of estrogen on the basal ganglia. Neurosci Biobehav Rev. 1986;10:1-14.
61. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosam Res. 2002;53:865-871.
62. Gundlah C, Lu NZ, Bethea CL. Ovarian steroid regulation of monoamine oxidase-A and -B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology (Berl). 2002;160:271-282.
63. Engelberg H. Low serum cholesterol and suicide. Lancet. 1992;339:727-729.
64. Ploeckinger B, Dantendorfer K, Ulm M, et al. Rapid decrease of serum cholesterol concentration and postpartum depression. BMJ. 1996;313:664.
65. Troisi A, Moles A, Panepuccia L, Lo Russo D, Palla G, Scucchi S. Serum cholesterol levels and mood symptoms in the postpartum period. Psychiatry Res. 2002;109:213-219.
66. Nasta MT, Grussu P, Quatraro RM, Cerutti R, Grella PV. Cholesterol and mood states at 3 days after delivery. J Psychosom Res. 2002;52:61-63.
67. van Dam RM, Schuit AJ, Schouten EG, Vader HL, Pop VJ. Serum cholesterol decline and depression in the postpartum period. J Psychosom Res. 1999;46:385-390.
68. De Vriese SR, Christophe AB, Maes M. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sci. 2003;73:318l-3187.
69. Hibbeln JR. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord. 2002;69:15-29.
70. Otto SJ, de Groot RH, Hornstra G. Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins Leukot Essent Fatty Acids. 2003;69:237-243.
71. De Wilde JP, Rivers AW, Price DL. A review of the currrent use of magnetic resonance imaging in pregnancy and safety implications for the fetus. Prog Biophys Mol Biol. 2005;87:335-353.
72. Holdcroft A, Hall L, Hamilton G, Counsell SJ, Bydder GM, Bell JD. Phosphorus-31 brain MR spectroscopy in women during and after pregnancy compared with nonpregnant control subjects. AJNR Am J Neuroradiol. 2005;26:352-356.
73. Anand A, Shekhar A. Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala. Ann N Y Acad Sci. 2003;985:370-388.
74. Sheline YI. Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry. 2003;54:338-352.
75. Maki PM, Resnick SM. Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies. Neuroimage. 2001;14:789-801.
76. Rode C, Wagner M, Gunturkun O. Menstrual cycle affects functional cerebral assymetries. Neuropsychologia. 1995;33:855-865.
77. Dietrich T, Krings T, Neulen J, et al. Effects of blood estrogen level on cortical activation patterns during cognitive activation as measured by functional MRI. Neuroimage. 2001;13:425-432.
78. Fernandez G, Weis S, Stoffel-Wagner B, et al. Menstrual cycle-dependent neural plasticity in the adult human brain is hormone, task, and region specific. J Neurosci. 2003;23:3790-3795.
79. Smith YR, Zubieta JK, del Carmen MG, et al. Brain opioid receptor measurements by positron emission tomography in normal cycling women: relationship to luteinizing hormone pulsatility and gonadal steroid hormones. J Clin Endocrinol Metab. 1998;83:4498-4505.
80. Rasgon NL, Thomas MA, Guze BH, et al. Menstrual cycle-related brain metabolite changes using 1H magnetic resonance spectroscopy in premenopausal women: a pilot study. Psychiatry Res. 2001;106:47-57.
81. Epperson CN, Haga K, Mason GF, et al. Neuroimaging studies of mood disorder effects on the brain. Arch Gen Psychiatry. 2002;59:851-858.